Tolazamide

CAS No. 1156-19-0

Tolazamide( NSC 70762 )

Catalog No. M10547 CAS No. 1156-19-0

Tolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 53 In Stock
2MG 29 In Stock
5MG 46 In Stock
10MG 61 In Stock
25MG 93 In Stock
50MG 118 In Stock
100MG 152 In Stock
200MG 226 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tolazamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Tolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes.
  • Description
    Tolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC 70762
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    Potassium Channel
  • Research Area
    Endocrinology
  • Indication
    ——

Chemical Information

  • CAS Number
    1156-19-0
  • Formula Weight
    311.4
  • Molecular Formula
    C14H21N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 65.4 mg/L (at 30 °C)
  • SMILES
    O=C(NS(=O)(C1=CC=C(C)C=C1)=O)NN2CCCCCC2
  • Chemical Name
    1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Szabo C, Salzman AL. Shock. 1996 Jun;5(6):391-4.
molnova catalog
related products
  • Doxapram hydrochlori...

    Doxapram hydrochloride hydrate inhibits TASK-1, TASK-3, TASK-1/TASK-3 heterodimeric channel function with EC50 of 410 nM, 37 μM, 9 μM, respectively.

  • Potassium Channel Ac...

    Potassium Channel Activator 1 can be used in studies about the treatment of disorders or conditions wherein the dopaminergic system is disrupted such as mood disorders ADHD, schizophrenia, and other psychotic states.

  • A2764 dihydrochlorid...

    A2764 dihydrochloride is a highly selective inhibitor of TRESK.